Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
ORTHOPEDICS AND TRAUMATOLOGY / BASIC RESEARCH
Suppression of lncRNA-MALAT1 activity ameliorates femoral head necrosis by modulating mTOR signaling
1
Department of Orthopaedics, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
2
Second Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, China
Submission date: 2019-09-09
Final revision date: 2019-12-02
Acceptance date: 2019-12-19
Online publication date: 2020-02-02
Publication date: 2024-04-23
Arch Med Sci 2024;20(2):612-617
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Avascular necrosis of the femoral head (ANFH) is one of the most complicated bone disorders; management remains challenging. We evaluated the effect of lncRNA-MALAT1 suppression on ANFH rats.
Material and methods:
Dexamethasone was injected intravenously at 0.5 mg/kg daily for 30 days to induce ANFH; an lncRNA-MALAT1 inhibitor group received the inhibitor for the entire 30 days. LncRNA-MALAT1 suppression was evaluated by measuring blood hexosamine and hydroxyproline levels, and that of circulating endothelial progenitor cells (EPCs). Changes in femoral head bone ultrastructure were assessed via transmission electron microscopy and magnetic resonance imaging (MRI). We used reverse transcription polymerase chain reaction (RT-PCR) and Western blotting to measure gene and protein expression levels in femoral head tissue.
Results:
The blood hexosamine level rose and that of hydroxyproline fell in the LncRNA-MALAT1 inhibitor group compared to the ANFH group. LncRNA-MALAT1 suppression increased the level of circulating EPCs. Ultrastructural changes in the femoral bone head were alleviated by the lncRNA-MALAT1 inhibitor. LncRNA-MALAT1 suppression lowered the levels of AMPK, mTOR, and Beclin-1 in rat tissue homogenates.
Conclusions:
LncRNA-MALAT1 suppression attenuated dexamethasone-induced femoral head necrosis by regulating AMPK/mTOR/Beclin-1 signaling.
Avascular necrosis of the femoral head (ANFH) is one of the most complicated bone disorders; management remains challenging. We evaluated the effect of lncRNA-MALAT1 suppression on ANFH rats.
Material and methods:
Dexamethasone was injected intravenously at 0.5 mg/kg daily for 30 days to induce ANFH; an lncRNA-MALAT1 inhibitor group received the inhibitor for the entire 30 days. LncRNA-MALAT1 suppression was evaluated by measuring blood hexosamine and hydroxyproline levels, and that of circulating endothelial progenitor cells (EPCs). Changes in femoral head bone ultrastructure were assessed via transmission electron microscopy and magnetic resonance imaging (MRI). We used reverse transcription polymerase chain reaction (RT-PCR) and Western blotting to measure gene and protein expression levels in femoral head tissue.
Results:
The blood hexosamine level rose and that of hydroxyproline fell in the LncRNA-MALAT1 inhibitor group compared to the ANFH group. LncRNA-MALAT1 suppression increased the level of circulating EPCs. Ultrastructural changes in the femoral bone head were alleviated by the lncRNA-MALAT1 inhibitor. LncRNA-MALAT1 suppression lowered the levels of AMPK, mTOR, and Beclin-1 in rat tissue homogenates.
Conclusions:
LncRNA-MALAT1 suppression attenuated dexamethasone-induced femoral head necrosis by regulating AMPK/mTOR/Beclin-1 signaling.
REFERENCES (22)
1.
Fondi C, Franchi A. Definition of bone necrosis by the pathologist. Clin Cases Miner Bone Metab 2007; 4: 21-6.
2.
Li HQ, Wu L, Jia ZP, Zhang XF, Sheng L. Investigation on mental health state of 37 patients of femoral head. Zhonghua Liu Xing Bing Xue Za Zhi 2012; 33: 1223.
3.
Stewart HL, Kawcak CE. The importance of subchondral bone in the pathophysiology of osteoarthritis. Front Vet Sci 2018; 5: 178.
4.
Goulden MR. The pain of chronic pancreatitis: a persistent clinical challenge. Br J Pain 2013; 7: 8-22.
5.
Wu B, Dong Z, Li S, Song H. Steroid-induced ischemic bone necrosis of femoral head: treatment strategies. Pak J Med Sci 2015; 31: 471-6.
6.
Pouya F, Kerachian MA. Avascular necrosis of the femoral head: are any genes involved? Arch Bone Jt Surg 2015; 3: 14-55.
7.
Yang DH, Yang MY. The role of macrophages in the pathogenesis of osteoporosis. Int J Mol Sci 2019; 20: E2093.
8.
Tye CE, Gordon JA, Martin-Buley LA, Stein JL, Lian JB, Stein GS. Could lncRNAs be the missing links in control of mesenchymal stem cell differentiation? J Cell Physiol 2015; 230: 526-34.
9.
Sun Y, Ma L. New insights into long non-coding RNA MALAT1 in cancer and metastasis. Cancers (Basel) 2019; 11: 216.
10.
Wang Y, Luo TB, Liu L, Cui ZQ. LncRNA LINC00311 promotes the proliferation and differentiation of osteoclasts in osteoporotic rats through the Notch signaling pathway by targeting DLL3. Cell Physiol Biochem 2018; 47: 2291-306.
11.
Zheng S, Wang YB, Yang YL, et al. LncRNA MALAT1 inhibits osteogenic differentiation of mesenchymal stem cells in osteoporosis rats through MAPK signaling pathway. Eur Rev Med Pharmacol Sci 2019; 23: 4609-17.
12.
Wei L, Li J, Han Z, Chen Z, Zhang Q. Silencing of lncRNA MALAT1 prevents inflammatory injury after lung transplant ischemia-reperfusion by downregulation of IL-8 via p300. Mol Ther Nucleic Acids 2019; 18: 285-97.
13.
Song Q, Ni J, Jiang H, Shi Z. Sildenafil improves blood perfusion in steroid-induced avascular necrosis of femoral head in rabbits via a protein kinase G-dependent mechanism. Acta Orthop Traumatol Turc 2017; 51: 398-403.
14.
Dwivedi D, Dwivedi M, Malviya S, Singh V. Evaluation of wound healing, anti-microbial and antioxidant potential of Pongamia pinnata in Wistar rats. J Tradit Complement Med 2016; 7: 79-85.
15.
Gold EW, Fox OD, Edgar PR., The effect of long term corticosteroid administration on lipid and prostaglandin levels. J Steroid Biochem 1978; 9: 313-6.
16.
Adikari M, Gunawardane A, Illangantilaka S, Atukorale H, Rubasinghe J. A case of systemic lupus erythematosus presenting as bilateral avascular necrosis of femur. BMC Res Notes 2016; 9: 392.
17.
Zhang M, Hu X. Mechanism of chlorogenic acid treatment on femoral head necrosis and its protection of osteoblasts. Biomed Rep 2016; 5: 57-62.
18.
Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998; 102: 274-82.
19.
Lodish H, Berk A, Zipursky SL, et al. Molecular Cell Biology. 4th edition. W.H. Freeman, New York 2000. Section 22.3, Collagen: The Fibrous Proteins of the Matrix.
20.
Shi B, Li G, Wang P, et al. Effect of antler extract on corticosteroid-induced avascular necrosis of the femoral head in rats. J Ethnopharmacol 2010; 127: 124-9.
21.
Feng Y, Yang SH, Xiao BJ, et al. Decreases in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head. Bone 2010; 46: 32-40.
22.
Zhu Z, Yang C, Iyaswamy A, et al. Balancing mTOR signaling and autophagy in the treatment of Parkinson’s Disease. Int J Mol Sci 2019; 20: 728.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
